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ABSTRACT 
Chemical investigation of the stem bark of Bauhinia rufescens resulted in the isolation of a 
new cyanoglucoside and menisdaurin from methanol extract and oxepin from petroleum ether 
extract. The isolated compounds were tested for their anti-inflammatory potentials based on 
the cyclooxygenase-2 enzyme (COX-2) model. Cyanoglucoside exhibited the highest activity 
among the compounds with an inhibition activity of 49.34 % at 100 µM (IC50 0.46 µM) com-
pared to the positive control, indomethacin (79.20 %, IC50 0.24 µM).  
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INTRODUCTION 
Prostaglandins are involved in diverse 
functions in a human body system, includ-
ing blood clotting, ovulation, bone metabo-
lism, nerve growth and development, 
wound healing, kidney function and im-
mune responses. Cyclooxygenase (COX) is 
an enzyme that catalyses cyclisation of ara-
chidonic acid to prostaglandins. Two 
isoforms of the enzyme have been identi-
fied as COX-1 and COX-2 (Dubois et al., 
1998; Huff et al., 2005). COX-1 is constitu-
tively expressed in a variety of cell types 
and is involved in regulating normal physi-
ological functions (Bertanha et al., 2012). 
Whereas, COX-2 isoform is induced by a 
variety of stimuli, such as lipopolysaccha-
rides and cytokines that are responsible for 
the biosynthesis of prostaglandins under in-
flammatory conditions (Blobaum and 
Marnett, 2007). Therefore, COX-2 is the 
target enzyme for the screening of anti-
inflammatory potential of a drug. 
Bauhinia rufescens Lam. (Fabaceae) 
known in northern part of Nigeria as ‘Mat-
satsagi’ is a tropical forage plant that grows 
up to 8 meters high (Balogun et al., 1998). 
It is used for the establishment of hedges, as 
well as an ornamental tree (Asiedu et al., 
2012). In folk medicine, the plant is used in 
the treatment of gout, gingivitis, diarrhea, 
dysentery, diabetes, leprosy and malaria 
(Compaoré et al., 2011; Tapsoba and De-
schamps, 2006; Jansen et al., 2010; Inngjer-
dingen et al., 2004; Maillard et al., 1991). 
Previous phytochemical and bioactivity stu-
dies in the genus Bauhinia have resulted in 
the isolation of anti-inflammatory com-
pounds including triterpenes from B. tara-
potensis (Sosa et al., 2002), dihydrodiben-
zooxepins from B. purpurea (Boonphong et 
al., 2007), and kaempferol and a triterpene 
caffeate from B. variegate (Rao et al., 
2008). Compaoré et al. (2011) reported the 
inhibition activities of the leaves and stem 
bark extracts of B. rufescens against 
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Figure 1: Structures of compounds 1-5 
 
 
xanthine oxidase and lipoxygenase enzy-
mes. In the present study, a new cyanoglu-
coside (1), menisdaurin (2) and oxepin (3) 
were isolated from the stem bark of B. ru-
fescens (Figure 1). Therefore, we would 
like to report structure elucidation of cy-
anoglucoside (1) and anti-inflammatory po-
tential of the isolated compounds against 
COX-2 enzyme. 
 
MATERIALS AND METHODS 
General 
Melting points (uncorrected) were deter-
mined using a Leica Gallen III Kofler micro 
melting point apparatus. UV spectra were 
measured with a Shimadzu UV 1601PC 
spectrophotometer, and IR spectra were 
recorded on a Perkin-Elmer 1600 FTIR 
spectrophotometer. The 1H- and 13C-NMR 
spectra were recorded on Bruker Avance 
400 MHz spectrometer. Chemical shifts 
were recorded in parts per million (δ) in ac-
etone-d6 and methanol-d4. Mass spectra 
were obtained from NUS Mass Spectrome-
try Service, Singapore. Column chromatog-
raphy was carried out on silica gel 70-230 
mesh (Merck). Silica gel 60 F254 precoated 
aluminium plates (0.2 mm, Merck) were 
used for TLC analysis; detection was per-
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formed by spraying with 5 % H2SO4 in 
methanol and 1 % vanillin in methanol, fol-
lowed by heating at 120 °C for 5 min. 
 
Plant material 
The stem bark of B. rufescens was col-
lected at Kiru, Kano State, Nigeria in Au-
gust 2011. A voucher specimen (Acc. 99) 
was deposited in the herbarium of the De-
partment of Biological Sciences, Bayero 
University, Kano, Nigeria. 
 
Extraction and isolation 
The dried stem bark of B. rufecsens 
(800 g) was ground and extracted succes-
sively with petroleum ether (4.0 L), ethyl 
acetate (4.0 L) and methanol (4.0 L) in a 
soxhlet extractor each for 18 h. The sam-
ples were concentrated using rotary evapo-
rator to give sticky brown substances of pe-
troleum ether (5.82 g, 0.73 %), ethyl acetate 
(12.51 g, 1.56 %) and methanol (44.93 g, 
5.62 %). 
The methanol extract (10.0 g) was frac-
tionated using VLC with chloroform-
methanol, ethyl acetate-methanol, acetone-
methanol and methanol gradient as eluents 
to afford 22 fractions. Fraction 10 was sub-
jected to further purification using column 
chromatography with n-hexane-chloroform, 
chloroform-methanol, acetone-methanol, 
methanol polarity gradient to afford com-
pounds (1, 74.2 mg, 13.98 %) and (2, 
39.7 mg, 7.48 %) as a brownish oil and 
flake substances respectively. 
The petroleum ether extract (5.0 g) of 
stem bark was purified over silica gel col-
umn using petroleum ether - diethyl ether - 
chloroform - ethyl acetate - methanol step 
gradient to afford 230 fractions. Further pu-
rification of fraction 62 with petroleum 
ether, diethyl ether and ethyl acetate in po-
larity gradient over a silica gel column 
yielded compound (3, 23.7 mg, 0.47 %).  
 
Cyanoglucoside 1 
Rf: 0.36 (CHCl3-MeOH, 3:2); IR (KBr): 
3283, 2220, 1629, 1022 cm-1; 1H NMR 
(400 MHz, methanol-d4): Table 1; 13C 
NMR (100 MHz methanol-d4): Table 1; 
ESI-MS: m/z (%) = 498.11 [M + H+] (19), 
339.6 (5), 197.9 (28), 169.0 (100), 144.9 
(18). 
 
COX-2 inhibitory assay 
The activity of the test compounds (fi-
nal concentrations of 100, 10, 1, 0.1 and 
0.01 µM) on COX-2 was determined by 
measuring prostaglandin E2 (PGE2) using a 
COX Inhibitor Screening Kit (Catalog No 
560131, Cayman Chemicals, Ann Arbor 
Michigan USA) as well as the reported 
method (Bertanha et al., 2012). Reaction 
mixtures (1.15 mL) containing the reaction 
buffer (950 µL), heme (10 µL), COX-2 (10 
µL) and sample/control (20 µL) were incu-
bated at 37 °C in a water bath for 15 min. 
The reaction was initiated by addition of ar-
achidonic acid (10 µL) at a final concentra-
tion of 100 µM. After 2 min incubation, the 
reactions were stopped by addition of 1 M 
HCl (50 µL), followed by saturated solution 
of stannous chloride (100 µL). Then, pros-
taglandins (PGs) were quantified by means 
of the ELISA method. The contents of the 
reaction tubes were diluted and transferred 
to a 96-well plate coated with a mouse anti-
rabbit IgG, followed by addition of the PG 
screening acetylcholinesterase tracer and 
the PG screening antiserum. Plates were in-
cubated in an orbital shaker for 18 h, at 
room temperature.  
The reaction mixtures were removed, 
and the wells were washed five times with a 
buffer containing 0.05 % Tween 20. 
Acetylthiocholine and 5,5’-dithio-bis-2-
nitro-benzoic acid known as Ellman’s rea-
gent (200 µL) was then added to each well, 
and the plate was incubated in an orbital 
shaker for 60 min, at room temperature, un-
til the control wells yielded an optical den-
sity lying between 0.3–0.8 at 415 nm. A 
standard curve with PG was generated from 
the same plate, which was used to quantify 
the PG levels produced in the presence of 
the samples. The compound DuP697 
(Cayman Chemicals) was used to standard-
ize the assay for COX-2 and indomethacin 
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was employed as positive control. Results 
were expressed as a percentage relative to a 
control (100 % initial activity, solvent-
treated samples). All determinations were 
performed in duplicate. Regression analysis 
(probit analysis, SPSS 16.0) was employed 
for the calculation of IC50 values. 
 
RESULTS AND DISCUSSION 
Isolation and characterization 
Compound 1 was purified from metha-
nol extract by chromatographic techniques 
as brownish oil. Its structure was elucidated 
by the analysis of the spectroscopic data 
comprises of IR, 1H NMR, 13C NMR, 2D-
NMR and MS. The absorption band at 
3283 cm-1 and 2220 cm-1 were attributed to 
the presence of hydroxyl and nitrile group 
respectively. A band for olefinic carbon at-
oms stretching was also observed at 
1629 cm-1. The 1H NMR data showed the 
presence of two singlets at δ 5.69 and 3.63 
which were assigned to olefinic and meth-
oxyl protons respectively. Two non-
equivalent methylene protons at δ 2.00 and 
1.89 were also observed. A number of 
peaks between δ 3.32 and 4.75 were at-
tributed to the presence of oxy-methylene 
and oxy-methine protons in the molecule. 
The 13C NMR data revealed the pres-
ence of 21 carbon atoms, which were clas-
sified as one methyl, two methylene, six-
teen methine and two quaternary carbon at-
oms. The HMQC experiment shows the 
correlation between proton atom and its 
corresponding carbon atom. Methoxyl 
group in the molecule showed a connection 
between 3.63 and 59.3, while each of the 
carbon atoms of the methylene group were 
connected to a two non-equivalent protons. 
The prominent correlation observed in the 
case of methine carbon atoms appeared in 
the connections of 5.69 and 94.2, 4.53 and 
103.9 were assigned to olefinic and ano-
meric carbon atoms respectively. The NMR 
data (Table 1) of the cyanomethylenecyclo-
hexylglucosyl and cyclitoyl moieties in the 
molecule were reported based on the data of 
cyanomethylenecyclohexylglucoside (4) 
and seqouyitol (5) compounds isolated from 
Simmondsia chinensis (Van Boven et al., 
1994) and Ceratonia siliqua (Baumgartner 
et al., 1986, Binder and Haddon, 1984) re-
spectively. The two parts were bonded to 
one another through a glycosidic bond be-
tween C-3′ and C-4′′ of cyanomethylenecy-
clohexylglucosyl and cyclitoyl parts respec-
tively. The correlation of the connected 
bonds was observed in HMBC experiment 
(Figure 2).  
Furthermore, the mass spectrum of 
compound 1 showed [M+1] ion at m/z 498 
corresponding to the molecular formula of 
C21H33O14N with a loss of a nitrile group 
(CN). The fragment ion at 169 corresponds 
to the cyanomethylenecyclohexyl part of 
the molecule (1A), however, the glucosyl-
cyclitol (1B) part was observed at m/z 339. 
Combination of the IR, NMR and MS data 
led to the conclusive identification of a new 
cyanoglucoside 1 as (Z)-2-(2-((2S,3S,4S, 
5R,6S)-3,5-dihydroxy-6-(hydroxyl-methyl)-
4-((1S,2R,3R,4S,5R,6S)-2,3,4,5-tetrahydro- 
xy-6-methoxycyclohexyloxy)tetrahydro- 
2H-pyran-2-yloxy)-3,4,6-trihydroxycyclo- 
hexylidene)acetonitrile.  
Compound 2 was also isolated from the 
methanol extract as a white flake substance, 
identified as menisdaurin which was previ-
ously isolated from B. sirindhorniae  
Figure 2: Selected HMBC of compound 1 
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Table 1: 1H- and 13C-NMR (400 and 100 MHz, resp.) spectral data for compound 1. δ in ppm, J in Hz 
Position δ(H) δ(C) COSY HMBC 
1 4.75 (d, J = 5.2) 80.4 H-2 H-1′ 
2 3.83 (t, J = 5.2) 74.0 H-1, H-3  
3 4.00 (m) 69.7 H-2  
4 2.00 (m), 1.89 (m) 38.6  H-2 
5 4.69 (dd, J = 8.4, 3.6) 66.8   
6 - 165.2   
7 5.69 (s) 94.2   
8 - 116.3  H-7 
1′ 4.53 (d, J = 7.6) 103.9 H-2′ C1 
2′ 3.57 (dd, J = 9.6, 7.6) 76.8 H-1′, H-3′  
3′ 3.40 (t, J = 9.6) 73.3 H-2′, H-4′ C4′′ 
4′ 3.33 (t, J = 9.6) 71.1   
5′ 3.30 (m) 76.5   
6′ 3.90 (dd, J = 12.0, 2.0), 3.70 (dd, J = 12.0, 5.2) 61.3   
1′′ 3.33 (dd, J = 3.2, 2.0) 72.8 H-2′′, H-6′′  
2′′ 3.87 (d, J = 2.0) 72.3 H-1′′  
3′′ 3.33 (dd, J = 3.2, 2.0) 72.0   
4′′ 3.73 (dd, J = 9.6, 2.0) 70.5  H-3′ 
5′′ 3.61 (t, J = 9.6) 83.4   
6′′ 3.73 (dd, J = 9.6, 2.0) 70.0 H-1′′  
OCH3 3.63 (s) 59.3   
 
 
(Athikomkulchai et al., 2003). Purification 
of petroleum ether extract over silica gel 
column chromatography yielded compound 
3 as a white solid identified as 6-methoxy-
7-methyl-8-hydroxydibenz[b,f]oxepin. The 
spectral data of compounds 2 and 3 were 
consistent with the reported data (Mu et al., 
2007; Athikomkulchai et al., 2003). 
 
Inhibition of COX-2 
Inhibition of COX-2 by the isolated 
compounds was analyzed in a cell-free im-
munoassay system, in which the enzyme 
was sourced from human recombinant en-
zyme. The degree of COX-2 inhibition by 
the isolated compounds was recorded as 
percentage inhibition of prostaglandin syn- 
Table 2: Inhibitory activity on COX-2 of the 
compounds 
Compounds Inhibition at 100 μM (%) 
IC50 
(μM) 
1 49.39 ± 2.17 0.46 
2 36.35 ± 8.70 72.28 
3 41.48 ± 3.71 101.16 
Indomethacina 79.20 ± 1.82 0.24 
1 = cyanoglucoside; 2 = menisdaurin; 3 = oxepin;  
a = positive control 
 
thesis. The results were expressed as mean 
± SEM as shown in Table 2. Each com-
pound was tested at final concentration of 
100, 10, 1, 0.1, 0.01 μM and a regression 
analysis was employed for the calculation 
of IC50. The incubation of COX-2 with 
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menisdaurin (2) and oxepin (3) at 100 μM 
yielded inhibition of 36.35 ± 8.70 % and 
41.48 ± 3.71 % respectively, whereas, cy-
anoglucoside 1 furnished the best value 
among the isolated compounds inhibiting 
the enzyme at 49.34 ± 2.17 %. However, 
the concentration of inhibition at 50 % was 
evaluated for each compound in which 
compounds 2 and 3 inhibited PG produc-
tion at a concentration greater than 
70.00 µM, while compound 1 showed inhi-
bition at 0.46 µM. The percentage inhibi-
tion and IC50 values of indomethacin used 
as a positive control is higher than that of 
the isolated compounds (79.20 ± 1.82 %, 
0.24 µM). 
Compound 1 and 2 are structurally quite 
similar, both have cyanomethylenecyclo-
hexylglucosyl moiety and differ in the pres-
ence of cyclitoyl substituent in compound 
1. This resulted in the higher number of hy-
droxyl groups in compound 1 compared to 
compound 2. This could explain the dispari-
ty in the percentage inhibition of the two 
compounds. Regarding the IC50 values of 
the isolated compounds, compound 1 has a 
value 2-fold lower than that of indometha-
cin. On the other hand compounds 2 and 3 
exhibited IC50 value of 300-fold and 400-
fold lower than that of the positive control 
indomethacin. This discrepancy could be 
related to the concentration independence 
of the compounds towards inhibition activi-
ty of COX-2 enzyme (Ángeles et al., 2012).  
 
CONCLUSIONS 
In conclusion the COX-2 inhibitors iso-
lated from B. rufescens could explain the 
use of its decoction in the treatment of gin-
givitis and other inflammations in West Af-
rica. This study reports the isolation and 
structure elucidation of cyanoglucoside 1 
for the first time and COX-2 inhibition ac-
tivity of the isolated compounds from the 
stem bark of B. rufescens. 
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